These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20966402)

  • 61. Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.
    Steen DL; Cannon CP; Lele SS; Rajapurkar MM; Mukhopadhyay B; Scirica BM; Murphy SA; Morrow DA
    Clin Cardiol; 2013 Mar; 36(3):139-45. PubMed ID: 23377899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis.
    Zhang S; Dai D; Wang X; Zhu H; Jin H; Zhao R; Jiang L; Lu Q; Yi F; Wan X; Cui H
    BMC Cardiovasc Disord; 2016 May; 16():82. PubMed ID: 27154403
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between Lipoprotein (a) level on admission and the incidence of subsequent cardiovascular events in patients with acute coronary syndrome.
    Zhou J; Cui X; Jin X; Zhou J; Fu M; Zhong C; Sun A; Hu K; Fu M; Ge J
    Int J Cardiol; 2012 Jul; 158(3):464-6. PubMed ID: 22633661
    [No Abstract]   [Full Text] [Related]  

  • 64. GROWTH DIFFERENTIATION FACTOR 15 AS A PROGNOSTIC MARKER OF CHRONIC HEART FAILURE PROGRESSION IN LONG-TERM FOLLOW-UP AFTER ACUTE CORONARY SYNDROME.
    Kopytsya M; Vyshnevska I; Protsenko O; Barahmeh H
    Georgian Med News; 2017 Oct; (271):61-66. PubMed ID: 29099703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Growth Differentiation Factor 15 (GDF15) as a Reliable Biomarker for Cardiovascular Risk Assessment.
    Ikeda Y; Kumagai H; Motozawa Y; Suzuki J
    Int Heart J; 2016; 57(1):1-2. PubMed ID: 26742705
    [No Abstract]   [Full Text] [Related]  

  • 66. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.
    Xu X; Li Z; Gao W
    Biomarkers; 2011 Sep; 16(6):466-75. PubMed ID: 21718220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipids and stroke: looking for risk in all the wrong places?
    Howard G; Goff DC
    Ann Neurol; 2011 Apr; 69(4):597-9. PubMed ID: 21520228
    [No Abstract]   [Full Text] [Related]  

  • 68. Betaine and secondary events in an acute coronary syndrome cohort.
    Lever M; George PM; Elmslie JL; Atkinson W; Slow S; Molyneux SL; Troughton RW; Richards AM; Frampton CM; Chambers ST
    PLoS One; 2012; 7(5):e37883. PubMed ID: 22649561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interleukin 17: an unlikely marker of acute coronary syndrome?
    Patel KD; Murphy RT; White M; Gasparro D; Kelleher DP; Ryan T; McManus R; Ryan AW
    Atherosclerosis; 2009 Jul; 205(1):33-4. PubMed ID: 19131064
    [No Abstract]   [Full Text] [Related]  

  • 70. Elderly patient with coronary heart disease: time for appraisal.
    Hanon O
    Arch Cardiovasc Dis; 2010 Jan; 103(1):1-2. PubMed ID: 20142113
    [No Abstract]   [Full Text] [Related]  

  • 71. Interleukin-10 and acute coronary syndromes.
    Ternavasio-de la Vega HG; Marcos M; González-Buitrago JM; Martín Luengo C
    Am J Med; 2012 May; 125(5):e15; author reply e17. PubMed ID: 22482854
    [No Abstract]   [Full Text] [Related]  

  • 72. Anti-inflammatory cytokines: a wolf in sheep's clothing?
    Tziakas DN; Chalikias GK; Kaski JC
    Am J Med; 2012 May; 125(5):e19; author reply e21. PubMed ID: 22482856
    [No Abstract]   [Full Text] [Related]  

  • 73. The association of short sleep after acute coronary syndrome with recurrent cardiac events and mortality.
    Alcántara C; Peacock J; Davidson KW; Hiti D; Edmondson D
    Int J Cardiol; 2014 Feb; 171(2):e11-2. PubMed ID: 24365609
    [No Abstract]   [Full Text] [Related]  

  • 74. C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it?
    Kaski JC
    Eur Heart J; 2010 Feb; 31(3):274-7. PubMed ID: 19854732
    [No Abstract]   [Full Text] [Related]  

  • 75. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction.
    Harb TS; Zareba W; Moss AJ; Ridker PM; Marder VJ; Rifai N; Miller Watelet LF; Arora R; Brown MW; Case RB; Dwyer EM; Gillespie JA; Goldstein RE; Greenberg H; Hochman J; Krone RJ; Liang CS; Lichstein E; Little W; Marcus FI; Oakes D; Sparks CE; VanVoorhees L;
    Am J Cardiol; 2002 Jan; 89(2):216-21. PubMed ID: 11792346
    [No Abstract]   [Full Text] [Related]  

  • 76. [Far from the clinical trial... close to our reality].
    Pérez de Isla L
    Rev Clin Esp; 2011 Dec; 211(11):579-80. PubMed ID: 22088664
    [No Abstract]   [Full Text] [Related]  

  • 77. Postmenopausal hormones and heart disease.
    Grady D; Hulley SB
    J Am Coll Cardiol; 2001 Jul; 38(1):8-10. PubMed ID: 11451299
    [No Abstract]   [Full Text] [Related]  

  • 78. Growth differentiation factor 15: A promising prognostic stratification biomarker in patients with acute coronary syndrome.
    Shang L; Feng M; Zhou X; Tang B
    Int J Cardiol; 2019 Dec; 297():16. PubMed ID: 31839197
    [No Abstract]   [Full Text] [Related]  

  • 79. Growth differentiation factor 15: a canary in a coal mine?
    Ho JE; Wang TJ
    Clin Chem; 2012 Jan; 58(1):3-5. PubMed ID: 22065154
    [No Abstract]   [Full Text] [Related]  

  • 80. Growth differentiation factor 15 in heart failure: an update.
    Wollert KC; Kempf T
    Curr Heart Fail Rep; 2012 Dec; 9(4):337-45. PubMed ID: 22961192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.